$3.56
0.0451.28%
Ult. Agg.: Oct 28, 1:18 PM
Ironwood Pharmaceuticals (IRWD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ironwood Pharmaceuticals (IRWD) ha pubblicato l'ultima guidance il agosto 6, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $460M - $485M per il periodo.
Rispetto alle previsioni precedenti, Ironwood Pharmaceuticals ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Ironwood Pharmaceuticals ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Ironwood Pharmaceuticals. 22
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.27 | $0.21 | $0.01 | $0.11 |
| Actual | $0.31 | $0.24 | $-0.01 | $0.24 |
| Surprise | +14.8% | +14.3% | -200.0% | +118.2% |
| Revenue | ||||
| Estimate | $118.0M | $88.4M | $51.7M | $72.8M |
| Actual | $113.0M | $106.5M | $47.7M | $122.1M |
| Surprise | -4.24% | +20.4% | -7.68% | +67.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.31 | $0.32 | $0.03 | $0.03 |
| Revenue | ||||
| Consensus | $127.1M | $122.2M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.31 | $0.27 | 14.8 % |
| Q1 | May 7, 2026 | $0.24 | $0.21 | 14.3 % |
| Q4 | Feb 25, 2026 | $-0.01 | $0.01 | -200.0 % |
| Q3 | Nov 10, 2025 | $0.24 | $0.11 | 118.2 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $113.04M | $118.04M | -4.24 % |
| Q1 | May 7, 2026 | $106.51M | $88.45M | 20.4 % |
| Q4 | Feb 25, 2026 | $47.71M | $51.68M | -7.68 % |
| Q3 | Nov 10, 2025 | $122.06M | $72.81M | 67.6 % |